Biotin-PEG4-NHS ester
目录号 | 数量 | 价格 | 提前通知时间 | 购买此产品 |
---|---|---|---|---|
2893-100mg | 100 mg | $145 | 现货 | |
2893-1g | 1 g | $590 | 现货 |
Biotin-PEG4-NHS ester is an activated ester for simple and efficient biotin labeling of antibodies, proteins, and other primary amine-containing biomolecules. The NHS ester group reacts efficiently with amino groups by the nucleophilic attack, forming an amide bond and releasing N-Hydroxysuccinimide. Biotin-labeled compounds can then be linked to avidin or streptavidin for further purification or detection. The biotin group is relatively small and doesn’t affect the biological activity of biotinylated proteins.
This reagent features a long PEG4-linker that separates the biotin residue from the target molecule, ensuring efficient binding to avidin or streptavidin. The linker also increases the compound’s water solubility, thereby facilitating bioconjugation. Antibodies labeled with Biotin-PEG4-NHS ester exhibit less aggregation when stored in solution than those labeled with reagents with only hydrocarbon spacers.
顾客还购买了这个产品
生物素亚磷酰胺(羟基脯氨醇) [Biotin phosphoramidite (hydroxyprolinol)]
生物素亚磷酰胺用于合成生物素化的寡核苷酸。含有二甲氧基三苯甲基基团。并获得免费的快递服务
sulfo-Cyanine5链霉亲和素 (sulfo-Cyanine5 streptavidin)
链霉亲和素的sulfo-Cyanine5 偶联物,是一种高亲和力的生物素结合蛋白,用于免疫荧光、蛋白质印迹、酶标仪和其他应用。Lumizol Reagent
Lumizol reagent is a solution for the rapid extraction of RNA, DNA, and proteins from various cell and tissue samples.General properties
Appearance: | white to off-beige powder |
Molecular weight: | 588.68 |
CAS number: | 459426-22-3 |
Molecular formula: | C25H40N4O10S |
Solubility: | water, DMSO, DMF, DCM |
Quality control: | NMR 1H and HPLC-MS (95+%) |
Storage conditions: | 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate. |
安全数据表(MSDS): | 下载 |
产品规格 |
产品引用
- Zhang, L.; Yang, C.; Li, Y.; Niu, S.; Liang, X.; Zhang, Z.; Luo, Q.; Luo, H. Dynamic Changes in the Levels of Amyloid-β 42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 2021, 14, 723317. doi: 10.3389/fnmol.2021.723317